Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q42793238 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241221010834.0 | ||
| 008 | 241221nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q42793238 | ||
| 024 | ‡a 0000-0001-5752-7653 ‡2 orcid | ||
| 024 | ‡a 9270641900 ‡2 scopus | ||
| 035 | ‡a (OCoLC)Q42793238 | ||
| 100 | 0 | ‡a Maria Ximena Rojas-reyes ‡c researcher ‡9 en | |
| 375 | ‡a 2 ‡2 iso5218 | ||
| 400 | 0 | ‡a Maria Ximena Rojas-reyes ‡c wetenschapper ‡9 nl | |
| 670 | ‡a Author's Chloroquine and hydroxychloroquine for the treatment of COVID-19: A living systematic review protocol | ||
| 670 | ‡a Author's Cochrane in context: Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children | ||
| 670 | ‡a Author's Combination inhaled steroid and long-acting beta2-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease | ||
| 670 | ‡a Author's Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants | ||
| 670 | ‡a Author's Effectiveness of the use of an algorithm in the diagnostic approach of joint pain patients by primary care physicians | ||
| 670 | ‡a Author's GRADE Guidelines: 19. Assessing the certainty of evidence describing the relative importance of outcomes or values and preferences -- Risk of bias and indirectness | ||
| 670 | ‡a Author's GRADE guidelines: 20. Assessing the certainty of evidence in the importance of outcomes or values and preferences—inconsistency, imprecision, and other domains | ||
| 670 | ‡a Author's Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children | ||
| 670 | ‡a Author's Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease | ||
| 670 | ‡a Author's Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease (COPD) | ||
| 670 | ‡a Author's Oral xanthine derivatives | ||
| 670 | ‡a Author's Oral xanthine derivatives (theophylline and doxofylline) for patients with stable chronic obstructive pulmonary disease (COPD) | ||
| 670 | ‡a Author's Oxygen therapy for lower respiratory tract infections in children between 3 months and 15 years of age | ||
| 670 | ‡a Author's Protein-free synthetic surfactant for the prevention and treatment of respiratory distress syndrome in neonates | ||
| 670 | ‡a Author's Rescue high-frequency jet ventilation versus conventional ventilation for severe pulmonary dysfunction in preterm infants | ||
| 670 | ‡a Author's The GRADE evidence-to-decision framework: a report of its testing and application in 15 international guideline panels | ||
| 670 | ‡a Author's Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach | ||
| 670 | ‡a Author's Validating the "FACE" instrument using stakeholder perceptions of Feasibility, Acceptability, Cost and Equity in guideline implementation | ||
| 670 | ‡a Author's Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birth weight infants | ||
| 909 | ‡a (orcid) 0000000157527653 ‡9 1 | ||
| 909 | ‡a (scopus) 9270641900 ‡9 1 | ||
| 919 | ‡a oralxanthinederivatives ‡A Oral xanthine derivatives ‡9 1 | ||
| 919 | ‡a chloroquineandhydroxychloroquineforthetreatmentofcovid19alivingsystematicreviewprotocol ‡A Chloroquine and hydroxychloroquine for the treatment of COVID-19: A living systematic review protocol ‡9 1 | ||
| 919 | ‡a cochraneincontextmonoclonalantibodyforreducingtheriskofrespiratorysyncytialvirusinfectioninchildren ‡A Cochrane in context: Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children ‡9 1 | ||
| 919 | ‡a combinationinhaledsteroidandlongactingbeta2agonistinadditiontotiotropiumversustiotropiumorcombinationaloneforchronicobstructivepulmonarydisease ‡A Combination inhaled steroid and long-acting beta2-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease ‡9 1 | ||
| 919 | ‡a comparisonofanimalderivedsurfactantsforthepreventionandtreatmentofrespiratorydistresssyndromeinpreterminfants ‡A Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants ‡9 1 | ||
| 919 | ‡a effectivenessoftheuseofanalgorithminthediagnosticapproachofjointpainpatientsbyprimarycarephysicians ‡A Effectiveness of the use of an algorithm in the diagnostic approach of joint pain patients by primary care physicians ‡9 1 | ||
| 919 | ‡a gradeguidelines19assessingthecertaintyofevidencedescribingtherelativeimportanceofoutcomesorvaluesandpreferencesriskofbiasandindirectness ‡A GRADE Guidelines: 19. Assessing the certainty of evidence describing the relative importance of outcomes or values and preferences -- Risk of bias and indirectness ‡9 1 | ||
| 919 | ‡a gradeguidelines20assessingthecertaintyofevidenceintheimportanceofoutcomesorvaluesandpreferencesinconsistencyimprecisionandotherdomains ‡A GRADE guidelines: 20. Assessing the certainty of evidence in the importance of outcomes or values and preferences—inconsistency, imprecision, and other domains ‡9 1 | ||
| 919 | ‡a monoclonalantibodyforreducingtheriskofrespiratorysyncytialvirusinfectioninchildren ‡A Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children ‡9 1 | ||
| 919 | ‡a 11dailylabaicscombinedinhalersversusinhaledlongactingbeta2agonistsforpeoplewithchronicobstructivepulmonarydisease ‡A Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease ‡9 1 | ||
| 919 | ‡a 11dailylabaicscombinedinhalersversusinhaledlongactingbeta2agonistsforpeoplewithchronicobstructivepulmonarydiseasecopd ‡A Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease (COPD) ‡9 1 | ||
| 919 | ‡a oralxanthinederivativestheophyllineanddoxofyllineforpatientswithstablechronicobstructivepulmonarydiseasecopd ‡A Oral xanthine derivatives (theophylline and doxofylline) for patients with stable chronic obstructive pulmonary disease (COPD) ‡9 1 | ||
| 919 | ‡a oxygentherapyforlowerrespiratorytractinfectionsinchildrenbetween3monthsand15yearsofage ‡A Oxygen therapy for lower respiratory tract infections in children between 3 months and 15 years of age ‡9 1 | ||
| 919 | ‡a proteinfreesyntheticsurfactantforthepreventionandtreatmentofrespiratorydistresssyndromeinneonates ‡A Protein-free synthetic surfactant for the prevention and treatment of respiratory distress syndrome in neonates ‡9 1 | ||
| 919 | ‡a rescuehighfrequencyjetventilationversusconventionalventilationforseverepulmonarydysfunctioninpreterminfants ‡A Rescue high-frequency jet ventilation versus conventional ventilation for severe pulmonary dysfunction in preterm infants ‡9 1 | ||
| 919 | ‡a gradeevidencetodecisionframeworkareportofitstestingandapplicationin15internationalguidelinepanels ‡A The GRADE evidence-to-decision framework: a report of its testing and application in 15 international guideline panels ‡9 1 | ||
| 919 | ‡a usingpatientvaluesandpreferencestoinformtheimportanceofhealthoutcomesinpracticeguidelinedevelopmentfollowingthegradeapproach ‡A Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach ‡9 1 | ||
| 919 | ‡a validatingthefaceinstrumentusingstakeholderperceptionsoffeasibilityacceptabilitycostandequityinguidelineimplementation ‡A Validating the "FACE" instrument using stakeholder perceptions of Feasibility, Acceptability, Cost and Equity in guideline implementation ‡9 1 | ||
| 919 | ‡a vitaminasupplementationtopreventmortalityandshortandlongtermmorbidityinverylowbirthweightinfants ‡A Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birth weight infants ‡9 1 | ||
| 946 | ‡a a ‡9 1 | ||
| 996 | ‡2 ISNI|0000000044226432 | ||
| 996 | ‡2 ISNI|0000000076384478 | ||
| 996 | ‡2 LC|n 93003709 | ||
| 996 | ‡2 NUKAT|n 2016159753 | ||
| 996 | ‡2 ISNI|0000000501369675 | ||
| 996 | ‡2 CAOONL|ncf11322826 | ||
| 996 | ‡2 BNF|17073675 | ||
| 996 | ‡2 LC|no2010187405 | ||
| 996 | ‡2 LC|no2012015644 | ||
| 996 | ‡2 LC|no2007062282 | ||
| 996 | ‡2 ISNI|0000000443635831 | ||
| 996 | ‡2 ISNI|000000011588672X | ||
| 996 | ‡2 LC|no2017148609 | ||
| 996 | ‡2 BNE|XX4939742 | ||
| 996 | ‡2 BIBSYS|6007640 | ||
| 996 | ‡2 DNB|1057323012 | ||
| 996 | ‡2 LC|no2020092960 | ||
| 996 | ‡2 LC|n 82218763 | ||
| 996 | ‡2 DNB|142478490 | ||
| 996 | ‡2 LC|ns2019003940 | ||
| 996 | ‡2 ISNI|0000000497477488 | ||
| 996 | ‡2 BNC|981061152904606706 | ||
| 996 | ‡2 SUDOC|05583812X | ||
| 996 | ‡2 LC|n 88620892 | ||
| 996 | ‡2 LC|no2007025842 | ||
| 996 | ‡2 ISNI|0000000045126062 | ||
| 996 | ‡2 ISNI|0000000357923511 | ||
| 996 | ‡2 ISNI|0000000052434063 | ||
| 996 | ‡2 LC|no2007078367 | ||
| 996 | ‡2 LC|n 83133153 | ||
| 996 | ‡2 ISNI|0000000498285920 | ||
| 996 | ‡2 ISNI|0000000083396338 | ||
| 996 | ‡2 BNC|981061119944106706 | ||
| 996 | ‡2 ISNI|0000000043198732 | ||
| 996 | ‡2 BNCHL|10000000000000000057414 | ||
| 996 | ‡2 SUDOC|142860077 | ||
| 996 | ‡2 BNE|XX4610709 | ||
| 996 | ‡2 BLBNB|000525524 | ||
| 996 | ‡2 LC|ns2012000551 | ||
| 996 | ‡2 BNC|981058518248706706 | ||
| 996 | ‡2 NTA|394548426 | ||
| 996 | ‡2 ISNI|0000000075387984 | ||
| 996 | ‡2 BNCHL|10000000000000000865676 | ||
| 996 | ‡2 NTA|377272736 | ||
| 996 | ‡2 ISNI|0000000076317611 | ||
| 996 | ‡2 LC|no2009093179 | ||
| 996 | ‡2 NTA|262883791 | ||
| 996 | ‡2 LC|ns2021001213 | ||
| 996 | ‡2 SUDOC|177119004 | ||
| 996 | ‡2 LC|nb2012029923 | ||
| 996 | ‡2 LC|no2011079149 | ||
| 996 | ‡2 LC|ns2012004559 | ||
| 996 | ‡2 BNE|XX5041561 | ||
| 996 | ‡2 LC|n 2013056583 | ||
| 996 | ‡2 DNB|1310527083 | ||
| 996 | ‡2 LC|no 97023562 | ||
| 996 | ‡2 CAOONL|ncf10379747 | ||
| 996 | ‡2 BNCHL|10000000000000000142255 | ||
| 996 | ‡2 LC|ns2023000502 | ||
| 996 | ‡2 LC|ns2016002969 | ||
| 996 | ‡2 BIBSYS|97036248 | ||
| 996 | ‡2 DNB|1223869393 | ||
| 996 | ‡2 LC|no2017138593 | ||
| 996 | ‡2 ARBABN|000070286 | ||
| 996 | ‡2 SUDOC|175698570 | ||
| 996 | ‡2 ISNI|0000000060375577 | ||
| 996 | ‡2 J9U|987007324406405171 | ||
| 996 | ‡2 ISNI|000000046342154X | ||
| 996 | ‡2 NSK|000658908 | ||
| 996 | ‡2 LC|no2017134489 | ||
| 996 | ‡2 SUDOC|114468621 | ||
| 996 | ‡2 PLWABN|9810531431005606 | ||
| 996 | ‡2 LC|n 2010183919 | ||
| 996 | ‡2 SUDOC|158629760 | ||
| 996 | ‡2 SUDOC|136494110 | ||
| 996 | ‡2 DNB|141542322 | ||
| 996 | ‡2 ISNI|0000000028122190 | ||
| 996 | ‡2 LC|no2004040599 | ||
| 996 | ‡2 BNE|XX5085163 | ||
| 996 | ‡2 SUDOC|276284925 | ||
| 996 | ‡2 LC|n 2013207796 | ||
| 996 | ‡2 ISNI|000000005937338X | ||
| 996 | ‡2 BNE|XX1076439 | ||
| 996 | ‡2 ISNI|0000000099648675 | ||
| 996 | ‡2 BNF|15660954 | ||
| 996 | ‡2 LC|no2011175478 | ||
| 996 | ‡2 LC|n 82218762 | ||
| 996 | ‡2 LC|no2002061844 | ||
| 996 | ‡2 J9U|987007346658505171 | ||
| 996 | ‡2 LC|no2002063077 | ||
| 996 | ‡2 LC|n 2011028136 | ||
| 996 | ‡2 NTA|322515750 | ||
| 996 | ‡2 LC|nb 98065302 | ||
| 996 | ‡2 LC|n 2015043547 | ||
| 996 | ‡2 BNCHL|10000000000000000139611 | ||
| 996 | ‡2 LC|no2010113155 | ||
| 996 | ‡2 DNB|1333450559 | ||
| 996 | ‡2 BNF|13613367 | ||
| 996 | ‡2 BNC|981058515203906706 | ||
| 996 | ‡2 ISNI|000000002719968X | ||
| 996 | ‡2 SUDOC|164637915 | ||
| 996 | ‡2 LC|n 2024051724 | ||
| 996 | ‡2 ISNI|0000000095025542 | ||
| 996 | ‡2 LC|no2009171466 | ||
| 996 | ‡2 BNE|XX1756715 | ||
| 996 | ‡2 RERO|A012671619 | ||
| 996 | ‡2 PTBNP|1486945 | ||
| 996 | ‡2 NUKAT|n 2004049657 | ||
| 996 | ‡2 BLBNB|000214897 | ||
| 996 | ‡2 LC|n 2021054420 | ||
| 996 | ‡2 SUDOC|280000014 | ||
| 996 | ‡2 PTBNP|108341 | ||
| 996 | ‡2 ISNI|0000000066389224 | ||
| 996 | ‡2 CAOONL|ncf10224277 | ||
| 996 | ‡2 ISNI|0000000030923149 | ||
| 996 | ‡2 NYNYRILM|361961 | ||
| 996 | ‡2 LC|no 97009538 | ||
| 996 | ‡2 J9U|987007439932105171 | ||
| 996 | ‡2 BNCHL|10000000000000000148081 | ||
| 996 | ‡2 J9U|987007403406805171 | ||
| 996 | ‡2 ISNI|000000003386288X | ||
| 996 | ‡2 LC|no2017063900 | ||
| 996 | ‡2 DNB|1057278319 | ||
| 996 | ‡2 LC|ns2021002222 | ||
| 996 | ‡2 LC|no2021059018 | ||
| 996 | ‡2 LC|no2011090234 | ||
| 996 | ‡2 LC|no2011090235 | ||
| 996 | ‡2 LC|no 99066143 | ||
| 996 | ‡2 BNE|XX6013780 | ||
| 996 | ‡2 SUDOC|195450329 | ||
| 996 | ‡2 LC|ns2015002788 | ||
| 996 | ‡2 NUKAT|n 2007090282 | ||
| 996 | ‡2 NUKAT|n 2011046892 | ||
| 996 | ‡2 CAOONL|ncf10547376 | ||
| 996 | ‡2 DNB|1089168233 | ||
| 996 | ‡2 RERO|A009244208 | ||
| 996 | ‡2 LC|no2001030733 | ||
| 996 | ‡2 BNCHL|10000000000000000074594 | ||
| 996 | ‡2 ISNI|0000000121445453 | ||
| 996 | ‡2 BNE|XX933591 | ||
| 996 | ‡2 LC|n 2003011155 | ||
| 996 | ‡2 BNCHL|10000000000000000046358 | ||
| 996 | ‡2 BNCHL|10000000000000000169576 | ||
| 996 | ‡2 ISNI|0000000062609269 | ||
| 996 | ‡2 LC|ns2014001835 | ||
| 996 | ‡2 DNB|1279293519 | ||
| 996 | ‡2 DNB|135920620 | ||
| 996 | ‡2 LC|n 87834024 | ||
| 996 | ‡2 CAOONL|ncf10724825 | ||
| 996 | ‡2 LC|ns2015000345 | ||
| 996 | ‡2 LC|no2012061155 | ||
| 996 | ‡2 PLWABN|9811520113005606 | ||
| 996 | ‡2 LC|no2011092794 | ||
| 996 | ‡2 ISNI|0000000027832529 | ||
| 996 | ‡2 BNCHL|10000000000000000294574 | ||
| 996 | ‡2 LC|no2008049611 | ||
| 996 | ‡2 ISNI|0000000500942265 | ||
| 996 | ‡2 BAV|495_135268 | ||
| 996 | ‡2 DNB|1057458562 | ||
| 996 | ‡2 ISNI|0000000119104326 | ||
| 996 | ‡2 BNE|XX929983 | ||
| 996 | ‡2 LC|no2009123191 | ||
| 996 | ‡2 BNF|15576119 | ||
| 996 | ‡2 BIBSYS|90219977 | ||
| 996 | ‡2 BNE|XX5545385 | ||
| 996 | ‡2 DNB|1057392057 | ||
| 996 | ‡2 BNF|15525476 | ||
| 996 | ‡2 ISNI|0000000032939726 | ||
| 996 | ‡2 LC|no2019184714 | ||
| 996 | ‡2 DNB|1057540706 | ||
| 996 | ‡2 RERO|A026659738 | ||
| 996 | ‡2 LC|no2015147497 | ||
| 996 | ‡2 LC|nr2006014484 | ||
| 996 | ‡2 ISNI|0000000049752781 | ||
| 996 | ‡2 SUDOC|26693921X | ||
| 996 | ‡2 DNB|159287189 | ||
| 996 | ‡2 DNB|1274121876 | ||
| 996 | ‡2 BNE|XX1059973 | ||
| 996 | ‡2 SUDOC|077813588 | ||
| 996 | ‡2 DNB|133489655 | ||
| 996 | ‡2 ARBABN|000058834 | ||
| 996 | ‡2 DNB|1057593885 | ||
| 996 | ‡2 LC|no2019055694 | ||
| 996 | ‡2 BNCHL|10000000000000000007220 | ||
| 996 | ‡2 DNB|1056606517 | ||
| 996 | ‡2 ISNI|0000000042913378 | ||
| 996 | ‡2 BNC|981058521453606706 | ||
| 996 | ‡2 ISNI|0000000120454534 | ||
| 996 | ‡2 CAOONL|ncf10710687 | ||
| 996 | ‡2 SUDOC|273615793 | ||
| 996 | ‡2 SUDOC|25331271X | ||
| 996 | ‡2 LC|n 2010065358 | ||
| 996 | ‡2 LC|no2007134379 | ||
| 996 | ‡2 LC|no2017155355 | ||
| 996 | ‡2 BNCHL|10000000000000000095763 | ||
| 996 | ‡2 ISNI|0000000059631596 | ||
| 996 | ‡2 BNE|XX1777815 | ||
| 996 | ‡2 BNC|981058507812406706 | ||
| 996 | ‡2 ISNI|0000000453100478 | ||
| 996 | ‡2 DNB|1056431326 | ||
| 996 | ‡2 LC|no2008006544 | ||
| 996 | ‡2 SUDOC|251567044 | ||
| 996 | ‡2 LC|no2010002835 | ||
| 996 | ‡2 ISNI|0000000121464523 | ||
| 996 | ‡2 ISNI|0000000498614245 | ||
| 996 | ‡2 ISNI|0000000434584278 | ||
| 996 | ‡2 DNB|137299710 | ||
| 996 | ‡2 ISNI|0000000023064040 | ||
| 996 | ‡2 LC|n 97013692 | ||
| 996 | ‡2 DNB|1163041130 | ||
| 996 | ‡2 LC|no2023068930 | ||
| 996 | ‡2 BNE|XX4900219 | ||
| 996 | ‡2 ISNI|0000000060741557 | ||
| 996 | ‡2 NUKAT|n 2004074739 | ||
| 996 | ‡2 SUDOC|06928329X | ||
| 996 | ‡2 LC|no2021149878 | ||
| 996 | ‡2 LC|no2017005880 | ||
| 996 | ‡2 LC|no2009154869 | ||
| 996 | ‡2 BNE|XX5420754 | ||
| 996 | ‡2 LC|n 2022041713 | ||
| 996 | ‡2 LC|n 83328981 | ||
| 996 | ‡2 SELIBR|275232 | ||
| 996 | ‡2 ISNI|0000000117374357 | ||
| 996 | ‡2 DNB|1103831755 | ||
| 996 | ‡2 LC|no 98126780 | ||
| 996 | ‡2 BIBSYS|8076158 | ||
| 996 | ‡2 NDL|00742822 | ||
| 996 | ‡2 ISNI|0000000000864184 | ||
| 996 | ‡2 DNB|1291310231 | ||
| 996 | ‡2 LC|no2021136811 | ||
| 996 | ‡2 ISNI|0000000378670525 | ||
| 996 | ‡2 ISNI|0000000049531129 | ||
| 996 | ‡2 ISNI|0000000077774144 | ||
| 996 | ‡2 ISNI|0000000048215191 | ||
| 996 | ‡2 BNCHL|10000000000000000829329 | ||
| 996 | ‡2 SUDOC|270876618 | ||
| 996 | ‡2 BNCHL|10000000000000000284638 | ||
| 996 | ‡2 LC|no2009155064 | ||
| 996 | ‡2 J9U|987007261209705171 | ||
| 996 | ‡2 PLWABN|9810646095105606 | ||
| 996 | ‡2 DNB|1057315222 | ||
| 996 | ‡2 J9U|987007428818205171 | ||
| 996 | ‡2 LC|no2019154077 | ||
| 996 | ‡2 LC|no2011090117 | ||
| 996 | ‡2 LC|no2015079292 | ||
| 996 | ‡2 LC|no2010086109 | ||
| 996 | ‡2 ISNI|0000000052341852 | ||
| 996 | ‡2 BNCHL|10000000000000000840947 | ||
| 996 | ‡2 ISNI|0000000036144963 | ||
| 996 | ‡2 BNC|981058514004306706 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
